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Arctium lappa is known to have antioxidant and antidiabetic effects in traditional medicine. Objectives: 
The aim of this paper was to study the effects of A. lappa root extract (AE) on lipid profile and hepatic 
enzyme levels in sucrose-induced metabolic syndrome (MS) in female rats. The study used 40 adult 
female Wistar rats weighing 150 g–250 g randomly divided into five groups: control, metabolic syndrome 
(MS), metabolic syndrome+AE at 50,100, 200 mg/kg. MS was induced by administering 50% sucrose 
in drinking water for 6 weeks. AE was intra-peritoneally administered daily at doses of 50,100, and 200 
mg/kg for two sequential weeks at the end of the fourth week in metabolic syndrome rats. Twenty-four 
hours after the last administration of AE, blood was collected and centrifuged, and then the serum was 
used for the measurement of lipid profile and hepatic enzyme. Serum glucose, insulin, fasting insulin 
resistance index, body weight, water intake, lipid profile, and hepatic enzymes were significantly 
increased although food intake was decreased in MS rats compared to the control rats. The lipids and 
liver enzymes were reduced by AE extracts in the MS group. This study showed that the A. lappa root 
aqueous extract exhibits a hypolipidemic activity of hyperlipidemic rats. This activity is practically that 
of a triple-impact antioxidant, hypolipidemic, and hepatoprotective.
Uniterms: Lappa arctium/effects. Metabolic syndrome. Sucrose/lipid profile/hepatic enzymes.
INTRODUCTION
Insulin resistance is the main characteristic of 
the metabolic syndrome (MS), a complex metabolic 
disorder described by hypertension, obesity, dyslipidemia, 
hyperinsulinemia, and type 2diabetes (T2DM). MS is 
a group of risk factors connected to cardiovascular and 
chronic liver disorders (Poruba et al., 2015; Flores et al., 
2016).
This syndrome has a high prevalence all over the 
world. Also, both environmental and genetic factors are 
known to relate to its progression. The recent increase in 
T2DM and MS is believed to be a consequence of a rise 
in inactive lifestyles combined with access to energy-rich 
food (Aguilera et al., 2004;  Vinagre et al., 2010). 
 An experimental model that resembles MS can be 
induced in rats by administering high-fructose or high-
sucrose (HS) diets.
Sucrose intake, in particular its fructose part induces 
the insulin resistance status (Aguilera et al., 2004). 
Fructose is converted into glycerol-3-phosphate, and 
acetyl-coenzymeA in the liver is used for very low-density 
lipoprotein (VLDL) production in the liver (Basciano, 
Federico, Adeli, 2005).
Insulin resistance increases hydrolysis of stored 
triglycerides in adipocytes and their presence in the blood 
stream, causing a decrease in plasma levels of HDL-c 
(Roselino et al., 2012).
The increases liver size and weight; moreover, 
the fatty liver observed in MS rats could contribute to 
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the progression of nonalcoholic steatosis induced by 
high sugar ingestion, is thought to be connected with 
obesity, hyperlipidemia, and diabetes (Aguilera et al., 
2004).
Previous studies found high plasma concentrations 
of alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST), approving hepatic tissue 
pathology in MS rats (Aguilera et al., 2004).
Herbal drugs utilized for the treatment of these 
conditions are extracts of plants affluent in antioxidants. 
Arctium lappa, L. (burdock) belongs to the Asteraceae 
family is cultivated in many countries, including Japan, 
and is greatly utilized in traditional medicine as a diuretic, 
antipyretic, or detoxifying agent (Predes et al., 2009) and 
also for the treatment of arthritis, hypertension, gout, 
arteriosclerosis, hepatitis, and tonsillitis.
The main active components separated from 
burdock are as follows: tannin, arctigenin, arctiin, 
beta-eudesmol, caffeic acid, chlorogenic acid, inulin, 
trachelogenin4, sitosterol-beta-D-glucopyranoside, 
lappaol, and diarctigenin (Chan et al., 2011).
Clinical trial studies show that burdock roots 
are hepatoprotective and have free radical scavenging 
effects in relation to the existence of caffeoylquinic acid 
derivatives (Feng et al., 2012). 
Cao et al. assayed the effects of burdock on 
streptozotocin-induced diabetic rats and realized that 
burdock’s root exhibits hypoglycemic activity (Cao et 
al., 2012).
Until now, no study has been done on the effects of 
burdock’s root in experimental animals on lipid profiles 
and hepatic enzymes. Therefore, this study was aimed to 
assess these parameters in MS rats.
MATERIAL AND METHODS
Plant and extract
Burdock root samples were gathered from different 
places in Iran and then scientifically confirmed by the 
Botany Department of AJUMS. Voucher specimens of 
the plant are deposited in the herbarium of the University 
of Khorassan, (Khorassan, Iran. No. IT-ES/HE 36942). 
Fresh roots of burdock were cut into small pieces, washed 
in water, and dried at a temperature not surpassing 40°C 
for a week in an oven )Fante, Dieterish, Rodriguez, 2008). 
Powder weighing 100 g was mixed in 200 ml of distilled 
water and boiled for 30 min. After the mixture was filtered 
by Whatman paper (No.1), the filtrate was centrifuged at 
3500 RMP for 15 min. The supernatant was evaporated at a 
temperature 40°C for 24 h and the acquired powder (46.5% 
and 46.5 g of root powder) was maintained at −20°C until 
utilized (Roghani et al., 2007; Li et al., 2016).
MS experimental model
A total of 40 adult female Wistar rats, which were 
normal, healthy, and nearly 150 g–250 g in body weight 
were purchased from the Physiology Center of Ahvaz. 
The rats were maintained in plastic cages at 25±2°C with 
a reverse 12-hour dark-light cycle and 65% ± 10% relative 
moistness. Food and water ad libitum during the study 
period. Our study was conducted in accordance with the 
guidelines for ethical laboratory animals’ maintenance 
of the AJUMS, and the investigation protocol was 
confirmed by the Research Ethics Committee of AJUMS 
and certificated under the number 88s113. After a week of 
adjustment, the rats were divided mainly into two groups, 
the control group (n = 8) that was fed a standard diet and 
the metabolic syndrome group (n = 32) that was fed the 
standard diet plus 50% sucrose in drinking water for 6 
weeks (Roghani et al., 2007).
Ten days before inducing the metabolic syndrome, 
every morning between 8 a.m. and 9 a.m., vaginal smears 
were taken for all groups, and then pro-estrus was a 
selective phase of this investigation (Santos et al., 2014).. 
The blood glucose level was measured by a glucometer 
(Elegans) at the end of the fourth and sixth weeks. MS rats 
exhibited blood glucose nearly 145 mg/dl–150 mg/dl and 
insulin resistance regarded to be MS status, and these are 
the criteria for inclusion into this study (Ahangarpour et 
al., 2013). The ingestion of food and water and the body 
weight were monitored during the experiments.
Experimental diet
After the animals received treatment, during the 6 
weeks, their insulin, glucose, lipid profile, and hepatic 
enzyme levels were measured.
Animals with MS, obtained as depicted above, 
were divided into four groups (n = 8), the metabolic 
syndrome group that was fed the standard diet without 
burdock extract and the metabolic syndrome groups that 
was fed the standard diet plus burdock extract (50, 100, 
200 mg/kg, IP) (Asgari et al., 2010). The burdock extract 
was administered daily for two sequential weeks from 
the end of the fourth week (Asgari et al., 2010). At 24 
hours after the end of IP injection, the rats were slightly 
anesthetized through the use of ether, and blood samples 
were acquired from the heart (Zamami et al., 2008). The 
blood was centrifuged at 3500 RMP for 20 min, and then 
the serum was separated. Serum was stored at −70°C 
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until assessment. The serum was utilized to determine 
the levels of several biochemical factors, including blood 
glucose, insulin (IRMA kit, DiaSource Belgium, INS), 
lipid profile, and hepatic enzymes, using commercial 
kits and enzyme methods (Pars azmoon, Iran). FIRI was 
computed via the formula: FIRI = fasting insulin (μIU/
ml) × fasting glucose (mg/dl) / 405. VLDL equals one-
fifth of the triglycerides quantity (Ahangarpour et al., 
2014).
Statistical Analysis
The results are presented as mean ± SD. The data 
was analyzed via the SPSS program. Comparison between 
control and MS rats was conducted by t-test, and the 
difference between the groups was determined by ANOVA 
and post-hoc LSD tests. The values were regarded as 
significant when p<0.05.
RESULTS AND DISCUSSION
Serum glucose, insulin, fasting insulin resistance 
index, body weight, food intake, water intake, lipid profile, 
and hepatic enzymes were analyzed by the MS model.
Serum glucose, AST (p<0.01), insulin, FIRI, TG, 
total cholesterol, ALP levels, body weight (p<0.001) and 
VLDL, water intake (p<0.05) were significantly increased 
although HDL (p<0.01), food intake (p<0.05) was 
decreased in MS rats compared to control rats (Table I). 
In this study, increased blood glucose, insulin, 
insulin resistance, body weight, water intake, TG, total 
cholesterol, VLDL, hepatic enzymes, and low HDL and 
food intake, are associated with MS, which agrees with 
previous studies (Ahangarpour, Yahyavi, 2011; Sampath, 
Karundevi, 2014). Sucrose administration can increase 
triglyceride levels via various mechanisms, including 
the liver’s extra production of VLDL-c triglycerides and 
their release in the bloodstream, decrease the lipoprotein 
lipase effect and the excretion of triglyceride by feces 
(Khan et al., 2015, Mousavi et al.; 2012). The increase of 
blood cholesterol is related to the reduction of endogenous 
cholesterol absorption or excretion (Khan et al., 2015). 
The elevation of plasma glucose and insulin, as well 
as FIRI, is related to the insulin resistance condition in 
the HS group. Abundant studies reported that a HS diet 
induces insulin resistance in animal models (Mousavi et 
al., 2012).
It has been regarded that insulin resistance and 
hyperinsulinemia play an important role in the cause 
of liver disorder. Hypersediment of fat in muscles 
and adipocytes characterizes insulin resistance with 
subsequent gathering of fat in the hepatocyte (Lima et 
al.; 2016), which raises the grade of mitochondrial beta-
oxidation of fatty acids and ketogenesis that may increase 
TABLE I - Serum glucose, insulin, fasting insulin resistance index, body weight, food intake, water intake, lipid profile and hepatic 
enzymes in metabolic syndrome (MS) model 
Groups Control n = 8
MS 
n = 8 p-value
Glucose(mg/dL) 101.43 ± 14.26 140.5 ± 18.73 a**
Insulin (μIU/mL) 0.82 ± 0.44 1.7 ± 0.89 a***
FIRI 3.36 ± 1.87 9.8 ± 4.02 a***
Body weight(g) 250 ± 12.3 280 ± 15.3 a***
Food intake(g/rat/day) 25.46 ± 19.2 19.53 ± 0.44 a*
Water intake(mL/rat/day) 24.0 6 ± 2.4 29.7 ± 2.5 a*
Cholesterol(mg/dL) 57.83 ± 4.6 87 ± 5.63 a***
TG (mg/dL) 67.16 ± 15.2 102.66 ± 13.2 a***
LDL (mg/dL) 45.4 ± 11 43.8 ± 11 
HDL (mg/dL) 45.83 ± 4.6 32.33 ± 5.37 a**
VLDL (mg/dL) 13.6 ± 3 20.53 ± 2.46 a*
AST(u/l) 112.42 ± 8.28 159.85 ± 21.5 a**
ALT(u/l) 62.42 ± 3.16 74 ± 2.63 
ALP(u/l) 125 ± 15.14 590.5 ± 62.52 a***
a = comparison between control group with MS group. T-test was performed for the differences among two groups. FIRI: Fasting 
Insulin Resistance Index. n = 8; mean ± SD, *= p < 0.05**= p < 0.01, ***= p < 0.001.
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lipid peroxidation and the gathering of reactive oxygen 
species (ROS) in the liver (Albano, Mottaran, Vidalli, 
2005). ROS produce a sort of cellular arousal with a 
subsequent inflammatory effect that has been known as the 
pathological agent of liver disorder (Marra et al., 2008).
Reduced insulin sensitivity also participates in lipid 
metabolism and hyperglycemia. Hypertriglyceridemia 
was demonstrated to be connected to liver disorder and 
increased FFA levels, which are responsible for increased 
insulin levels (Marchesini et al., 2001).
Hyperglycemia in MS is associated with a large 
ROS generation and critical oxidative damage in various 
tissues, such as those of the liver. Lipid peroxidation 
and raised ROS have been identified as factors of 
decreasing antioxidant defense (Silva et al., 2016). It was 
demonstrated that the extreme plasma-free fatty acids and 
glucose levels can be related to insulin resistance (Arner, 
2002, Tomas et al., 2002).
Effect of AE on lipid profile
Intake of Arctium lappa L. root extract was 
significantly decreased serum total cholesterol, TG 
(50,100, 200 mg/kg), serum LDL, HDL (200 mg/kg), 
VLDL (100, 200 mg/kg) levels (p<0.001), HDL, LDL at 
50, 100 mg/kg (p < 0.01) and VLDL at 50 mg/kg (p<0.05) 
compared to MS rats (Table II). 
The levels of serum total cholesterol, LDL, HDL, 
VLDL, and TG returned to the normal range due to AE 
administration in MS rats. 
Surplus adipose tissue secretes various compounds, 
such as FFAs, adiponectin, and cytokines. Increased 
FFA levels indicate that increased muscle with fat in the 
liver is responsible for increased insulin level and insulin 
resistance. It seems that weight gain leads to insulin 
resistance.
Hyperinsulinemia can enhance the production of 
very-low-density lipoprotein and triglycerides. Insulin 
resistance in muscles leads to glucose intolerance and 
hyperglycemia, which may be aggravated via enhanced 
liver gluconeogenesis (Scott et al., 2004).
The hypolipidemic effect of the burdock in the 
present investigation is in agreement with results on 
diabetic rats. Previous studies indicated that burdock 
root extract administration was associated with the 
improvement of glycogen content in the liver and muscles, 
lipid metabolism, and blood glucose in diabetic rats (Cao 
et al., 2012). The hypolipidemic effect of burdock might 
be related, in part, to its antioxidative activity, which 
decreases the oxidative stress of hepatocytes, or to other 
unknown protective mechanism(s), such as the declination 
in the TG liver and muscle content, fat accumulation, 
serum insulin, insulin resistance, and glucose.
Burdock includes a wide range of effective 
pharmacological compounds, such as polyphenolics, 
phenolic acid, flavonoid, and chlorogenic acid (Faulkner, 
King, 1976). Chlorogenic acids exhibit hypoglycemic 
activity besides reducing triglyceride and cholesterol 
levels (Cao et al., 2012). AE is a flavonoid-abundant 
extract. Flavonoids exhibiting insulin-like behavior have 
been separated from the plant. Some sorts of flavonoids 
can delete the lipid synthesis and release from hepatocytes 
(Hii et al., 1985). The cholesterol-diminishing activity of 
burdock is mainly in consequence of the reduction of its 
absorption in the intestinal tract via lowering pancreatic 
lipase, elevating lipoprotein lipase activity, and increase 
TABLE II - Effect of Arctium lappa L extract on total cholesterol, TG, LDL, HDL and VLDL levels in metabolic syndrome (MS) rats 
Groups Control n = 8
MS 
n = 8
Extract 
(50 mg/kg)  
n = 8
Extract 
(100 mg/kg) 
n = 8
Extract 
(200 mg/k) 
n = 8
p-value
Cholesterol (mg/dL) 57.83 ± 4.6 87 ± 5.63 61.85 ± 4.37 57.71 ± 3.23 52.23 ± 3.99 acde***
TG (mg/dL) 67.16 ± 15.2 102.66 ± 13.2 73.71 ± 19.55 65.71 ± 3.77 60.57 ± 8.95 acde***
LDL (mg/dL) 45.4 ± 11 43.8 ± 11 37.06 ± 5.05 35.67 ± 3.6 22.35 ± 5.3 cd** e***
HDL (mg/dL) 45.83 ± 4.6 32.33 ± 5.37 47.71 ± 4.97 52.61 ± 4.12 64.42 ± 3.49 acd**e***
VLDL (mg/dL) 13.6 ± 3 20.53 ± 2.46 14.74 ± 3.91 13.14 ± 1.75 12.11 ± 1.79 ac*de***
a = comparison between control group with MS group. c = comparison between extract at 50 mg/kg group with MS group. 
d = comparison between extract at 100 mg/kg group with MS group. e = comparison between extract at 200 mg/kg group with 
MS group. Triacylglycerol(TG), low density lipoprotein (LDL), high density lipoprotein (HDL), and very low density lipoprotein 
(VLDL).One-way analysis of variance (ANOVA) and post-hoc least significant difference (LSD) tests were performed for the 
differences among groups n = 8; mean ± SD, *p < 0.05, **= p < 0.01, ***= p < 0.001.
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in liver secretion. Polyphenolics may perform their 
hypolipidemic activity via the elevation of liver LDL 
receptors (Samah et al., 2016).
Effect of AE on hepatic enzymes
Arctium lappa L extract AST, ALT, ALP (100, 
200 mg/kg) levels (P < 0.01) AST at 50 mg/kg (P < 0.05) 
was significantly decreased serum (Table III).
The increase in the level of these enzymes in 
hyperlipidemic rats depicts an elevation in oxidative 
agents in consequence of the high plasma lipid level. The 
results of this study are in agreement with those of various 
previous investigations that demonstrate elevated plasma 
lipids, decreased antioxidant defenses, and elevated lipid 
peroxidation in the liver (Ghosian Moghaddm, Roghani, 
Maleki, 2016). Our results show that ALT and AST activity 
in the burdock-administered rats had decreased. The 
antioxidant effects of burdock have been demonstrated in 
terms of MDA, CAT, and GSH-Px tests in high-fat-diet 
rats (Wang et al., 2016).
The hepatoprotective mechanism of burdock might 
be related, in part, to its antioxidative effect, which reduces 
the oxidative stress in liver cells. This result is supported 
via previous studies on the hepatoprotective effect related 
to reducing fat accumulation, lipid peroxidation, and free 
radical scavenging effects of the plant (Lin et al., 2002). 
ALP accumulates in the bile duct and is frequently used 
to detect the integrity of the liver plasma membrane. 
Rising total ALP levels in plasma is associated with the 
elevated osteoplastic effect and described via some level of 
cholestasis. The present investigation reveals that the ALP 
level of HS-diet-fed rats were elevated. This increase is 
caused by de novo synthesis in hepatocytes and a reduction 
in the biliary release of bile acids and glutathione, which is 
a credible marker of liver disorder (Zagorova et al., 2015). 
Administering burdock caused reduced plasma ALP levels 
in MS rats. The reduction of the enzyme level is a clear 
sign of the hepatoprotective effect (Saleh et al., 2015).
Further investigations are needed to recognize the 
exact molecular mechanisms by which AE improves 
hepatic enzymes and blood lipids in MS rats.
In conclusion, this study showed that the burdock 
aqueous extract exhibits hypolipidemic activity in 
hyperlipidemic rats. This activity is practically that 
of a triple-impact antioxidant, hypolipidemic, and 
hepatoprotective. The burdock can defend cells from 
fat accumulation and oxidative stress. These effects are 
clearly derived from its high levels of flavonoids and 
polyphenolics.
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